nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrochlorothiazide—KCNMA1—blood vessel—malignant glioma	0.0228	0.0972	CbGeAlD
Hydrochlorothiazide—Encephalopathy—Carmustine—malignant glioma	0.0143	0.0206	CcSEcCtD
Hydrochlorothiazide—KCNMA1—brainstem—malignant glioma	0.0124	0.0531	CbGeAlD
Hydrochlorothiazide—KCNMA1—retina—malignant glioma	0.012	0.0513	CbGeAlD
Hydrochlorothiazide—Memory impairment—Temozolomide—malignant glioma	0.0113	0.0163	CcSEcCtD
Hydrochlorothiazide—KCNMA1—telencephalon—malignant glioma	0.011	0.0471	CbGeAlD
Hydrochlorothiazide—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.0108	0.0156	CcSEcCtD
Hydrochlorothiazide—CA12—telencephalon—malignant glioma	0.0106	0.0452	CbGeAlD
Hydrochlorothiazide—Coordination abnormal—Carmustine—malignant glioma	0.00936	0.0135	CcSEcCtD
Hydrochlorothiazide—Coordination abnormal—Temozolomide—malignant glioma	0.00904	0.013	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal pain—Temozolomide—malignant glioma	0.00899	0.013	CcSEcCtD
Hydrochlorothiazide—CA1—telencephalon—malignant glioma	0.00839	0.0358	CbGeAlD
Hydrochlorothiazide—Aplastic anaemia—Temozolomide—malignant glioma	0.00834	0.012	CcSEcCtD
Hydrochlorothiazide—CA9—cerebellum—malignant glioma	0.00796	0.034	CbGeAlD
Hydrochlorothiazide—KCNMA1—midbrain—malignant glioma	0.00793	0.0339	CbGeAlD
Hydrochlorothiazide—Diabetes mellitus—Carmustine—malignant glioma	0.00767	0.0111	CcSEcCtD
Hydrochlorothiazide—Swelling—Carmustine—malignant glioma	0.00756	0.0109	CcSEcCtD
Hydrochlorothiazide—CA4—brainstem—malignant glioma	0.00739	0.0315	CbGeAlD
Hydrochlorothiazide—Gastroenteritis—Temozolomide—malignant glioma	0.00727	0.0105	CcSEcCtD
Hydrochlorothiazide—Injury—Carmustine—malignant glioma	0.00726	0.0105	CcSEcCtD
Hydrochlorothiazide—Vascular purpura—Temozolomide—malignant glioma	0.00721	0.0104	CcSEcCtD
Hydrochlorothiazide—Nasal congestion—Temozolomide—malignant glioma	0.00708	0.0102	CcSEcCtD
Hydrochlorothiazide—Hot flush—Temozolomide—malignant glioma	0.00689	0.00994	CcSEcCtD
Hydrochlorothiazide—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00683	0.00985	CcSEcCtD
Hydrochlorothiazide—Menopausal symptoms—Temozolomide—malignant glioma	0.00683	0.00985	CcSEcCtD
Hydrochlorothiazide—Thirst—Temozolomide—malignant glioma	0.00677	0.00977	CcSEcCtD
Hydrochlorothiazide—Hyponatraemia—Carmustine—malignant glioma	0.0067	0.00966	CcSEcCtD
Hydrochlorothiazide—Purpura—Temozolomide—malignant glioma	0.00669	0.00964	CcSEcCtD
Hydrochlorothiazide—CA2—embryo—malignant glioma	0.00669	0.0285	CbGeAlD
Hydrochlorothiazide—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00667	0.00962	CcSEcCtD
Hydrochlorothiazide—CA4—telencephalon—malignant glioma	0.00656	0.028	CbGeAlD
Hydrochlorothiazide—Face oedema—Carmustine—malignant glioma	0.00644	0.00929	CcSEcCtD
Hydrochlorothiazide—Affect lability—Temozolomide—malignant glioma	0.00634	0.00915	CcSEcCtD
Hydrochlorothiazide—KCNMA1—central nervous system—malignant glioma	0.00628	0.0268	CbGeAlD
Hydrochlorothiazide—Ataxia—Carmustine—malignant glioma	0.00627	0.00904	CcSEcCtD
Hydrochlorothiazide—Face oedema—Temozolomide—malignant glioma	0.00622	0.00897	CcSEcCtD
Hydrochlorothiazide—Liver function test abnormal—Carmustine—malignant glioma	0.00616	0.00888	CcSEcCtD
Hydrochlorothiazide—KCNMA1—cerebellum—malignant glioma	0.00614	0.0262	CbGeAlD
Hydrochlorothiazide—CA2—brainstem—malignant glioma	0.00613	0.0262	CbGeAlD
Hydrochlorothiazide—Mood swings—Temozolomide—malignant glioma	0.00611	0.00881	CcSEcCtD
Hydrochlorothiazide—Hypokalaemia—Carmustine—malignant glioma	0.00607	0.00875	CcSEcCtD
Hydrochlorothiazide—Ataxia—Temozolomide—malignant glioma	0.00606	0.00874	CcSEcCtD
Hydrochlorothiazide—CA12—central nervous system—malignant glioma	0.00602	0.0257	CbGeAlD
Hydrochlorothiazide—CA2—retina—malignant glioma	0.00591	0.0252	CbGeAlD
Hydrochlorothiazide—Dry skin—Temozolomide—malignant glioma	0.00591	0.00852	CcSEcCtD
Hydrochlorothiazide—Muscular weakness—Carmustine—malignant glioma	0.00588	0.00848	CcSEcCtD
Hydrochlorothiazide—CA1—spinal cord—malignant glioma	0.00588	0.0251	CbGeAlD
Hydrochlorothiazide—Hypokalaemia—Temozolomide—malignant glioma	0.00587	0.00846	CcSEcCtD
Hydrochlorothiazide—Breast disorder—Temozolomide—malignant glioma	0.00583	0.0084	CcSEcCtD
Hydrochlorothiazide—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.0058	0.00837	CcSEcCtD
Hydrochlorothiazide—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.0058	0.00837	CcSEcCtD
Hydrochlorothiazide—Dysphagia—Carmustine—malignant glioma	0.00577	0.00831	CcSEcCtD
Hydrochlorothiazide—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00569	0.0082	CcSEcCtD
Hydrochlorothiazide—Muscular weakness—Temozolomide—malignant glioma	0.00569	0.0082	CcSEcCtD
Hydrochlorothiazide—Abdominal distension—Temozolomide—malignant glioma	0.00561	0.00809	CcSEcCtD
Hydrochlorothiazide—Dysphagia—Temozolomide—malignant glioma	0.00557	0.00803	CcSEcCtD
Hydrochlorothiazide—CA2—telencephalon—malignant glioma	0.00544	0.0232	CbGeAlD
Hydrochlorothiazide—CA5B—central nervous system—malignant glioma	0.0054	0.023	CbGeAlD
Hydrochlorothiazide—Neutropenia—Carmustine—malignant glioma	0.00539	0.00777	CcSEcCtD
Hydrochlorothiazide—SLC22A6—brain—malignant glioma	0.00534	0.0228	CbGeAlD
Hydrochlorothiazide—Dysuria—Temozolomide—malignant glioma	0.00521	0.00751	CcSEcCtD
Hydrochlorothiazide—Neutropenia—Temozolomide—malignant glioma	0.00521	0.00751	CcSEcCtD
Hydrochlorothiazide—Hyperglycaemia—Carmustine—malignant glioma	0.0052	0.0075	CcSEcCtD
Hydrochlorothiazide—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00518	0.00747	CcSEcCtD
Hydrochlorothiazide—Pneumonia—Carmustine—malignant glioma	0.00517	0.00746	CcSEcCtD
Hydrochlorothiazide—CA4—medulla oblongata—malignant glioma	0.00515	0.022	CbGeAlD
Hydrochlorothiazide—Pollakiuria—Temozolomide—malignant glioma	0.00515	0.00742	CcSEcCtD
Hydrochlorothiazide—Erectile dysfunction—Temozolomide—malignant glioma	0.00513	0.0074	CcSEcCtD
Hydrochlorothiazide—Photosensitivity reaction—Temozolomide—malignant glioma	0.00509	0.00733	CcSEcCtD
Hydrochlorothiazide—Weight increased—Temozolomide—malignant glioma	0.00507	0.00731	CcSEcCtD
Hydrochlorothiazide—Renal failure—Carmustine—malignant glioma	0.00505	0.00729	CcSEcCtD
Hydrochlorothiazide—Neuropathy peripheral—Carmustine—malignant glioma	0.00504	0.00727	CcSEcCtD
Hydrochlorothiazide—Hyperglycaemia—Temozolomide—malignant glioma	0.00503	0.00725	CcSEcCtD
Hydrochlorothiazide—Urinary tract infection—Carmustine—malignant glioma	0.005	0.00721	CcSEcCtD
Hydrochlorothiazide—Pneumonia—Temozolomide—malignant glioma	0.005	0.0072	CcSEcCtD
Hydrochlorothiazide—KCNMA1—brain—malignant glioma	0.00499	0.0213	CbGeAlD
Hydrochlorothiazide—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00492	0.0071	CcSEcCtD
Hydrochlorothiazide—Neuropathy peripheral—Temozolomide—malignant glioma	0.00487	0.00702	CcSEcCtD
Hydrochlorothiazide—Urinary tract infection—Temozolomide—malignant glioma	0.00483	0.00696	CcSEcCtD
Hydrochlorothiazide—CA12—brain—malignant glioma	0.00478	0.0204	CbGeAlD
Hydrochlorothiazide—CA1—central nervous system—malignant glioma	0.00477	0.0204	CbGeAlD
Hydrochlorothiazide—CA4—midbrain—malignant glioma	0.00471	0.0201	CbGeAlD
Hydrochlorothiazide—Sinusitis—Temozolomide—malignant glioma	0.00466	0.00672	CcSEcCtD
Hydrochlorothiazide—CA4—spinal cord—malignant glioma	0.0046	0.0196	CbGeAlD
Hydrochlorothiazide—Hypoaesthesia—Carmustine—malignant glioma	0.00459	0.00662	CcSEcCtD
Hydrochlorothiazide—Oedema peripheral—Carmustine—malignant glioma	0.00455	0.00656	CcSEcCtD
Hydrochlorothiazide—Hepatitis—Temozolomide—malignant glioma	0.00446	0.00643	CcSEcCtD
Hydrochlorothiazide—Visual impairment—Carmustine—malignant glioma	0.00445	0.00641	CcSEcCtD
Hydrochlorothiazide—Hypoaesthesia—Temozolomide—malignant glioma	0.00444	0.0064	CcSEcCtD
Hydrochlorothiazide—Pharyngitis—Temozolomide—malignant glioma	0.00443	0.00638	CcSEcCtD
Hydrochlorothiazide—Oedema peripheral—Temozolomide—malignant glioma	0.00439	0.00633	CcSEcCtD
Hydrochlorothiazide—Visual impairment—Temozolomide—malignant glioma	0.0043	0.0062	CcSEcCtD
Hydrochlorothiazide—CA5B—brain—malignant glioma	0.00429	0.0183	CbGeAlD
Hydrochlorothiazide—Flushing—Carmustine—malignant glioma	0.00428	0.00618	CcSEcCtD
Hydrochlorothiazide—CA2—medulla oblongata—malignant glioma	0.00427	0.0182	CbGeAlD
Hydrochlorothiazide—Erythema multiforme—Temozolomide—malignant glioma	0.00422	0.00608	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—YEATS4—malignant glioma	0.00421	0.0584	CbGpPWpGaD
Hydrochlorothiazide—Tinnitus—Temozolomide—malignant glioma	0.00416	0.006	CcSEcCtD
Hydrochlorothiazide—Flushing—Temozolomide—malignant glioma	0.00414	0.00597	CcSEcCtD
Hydrochlorothiazide—Arrhythmia—Carmustine—malignant glioma	0.00412	0.00594	CcSEcCtD
Hydrochlorothiazide—Alopecia—Carmustine—malignant glioma	0.00408	0.00588	CcSEcCtD
Hydrochlorothiazide—Erythema—Carmustine—malignant glioma	0.00402	0.00579	CcSEcCtD
Hydrochlorothiazide—Alopecia—Temozolomide—malignant glioma	0.00394	0.00568	CcSEcCtD
Hydrochlorothiazide—CA2—midbrain—malignant glioma	0.00391	0.0167	CbGeAlD
Hydrochlorothiazide—Back pain—Carmustine—malignant glioma	0.00389	0.0056	CcSEcCtD
Hydrochlorothiazide—Erythema—Temozolomide—malignant glioma	0.00388	0.0056	CcSEcCtD
Hydrochlorothiazide—CA2—spinal cord—malignant glioma	0.00381	0.0163	CbGeAlD
Hydrochlorothiazide—Dysgeusia—Temozolomide—malignant glioma	0.0038	0.00548	CcSEcCtD
Hydrochlorothiazide—CA1—brain—malignant glioma	0.00379	0.0162	CbGeAlD
Hydrochlorothiazide—Vision blurred—Carmustine—malignant glioma	0.00379	0.00546	CcSEcCtD
Hydrochlorothiazide—Tremor—Carmustine—malignant glioma	0.00376	0.00543	CcSEcCtD
Hydrochlorothiazide—Back pain—Temozolomide—malignant glioma	0.00376	0.00541	CcSEcCtD
Hydrochlorothiazide—CA4—central nervous system—malignant glioma	0.00373	0.0159	CbGeAlD
Hydrochlorothiazide—Anaemia—Carmustine—malignant glioma	0.00371	0.00535	CcSEcCtD
Hydrochlorothiazide—Agitation—Carmustine—malignant glioma	0.00369	0.00532	CcSEcCtD
Hydrochlorothiazide—Vision blurred—Temozolomide—malignant glioma	0.00366	0.00528	CcSEcCtD
Hydrochlorothiazide—CA4—cerebellum—malignant glioma	0.00364	0.0156	CbGeAlD
Hydrochlorothiazide—Tremor—Temozolomide—malignant glioma	0.00364	0.00524	CcSEcCtD
Hydrochlorothiazide—Ill-defined disorder—Temozolomide—malignant glioma	0.0036	0.00519	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Carmustine—malignant glioma	0.0036	0.00519	CcSEcCtD
Hydrochlorothiazide—Anaemia—Temozolomide—malignant glioma	0.00359	0.00517	CcSEcCtD
Hydrochlorothiazide—Agitation—Temozolomide—malignant glioma	0.00357	0.00514	CcSEcCtD
Hydrochlorothiazide—Angioedema—Temozolomide—malignant glioma	0.00355	0.00511	CcSEcCtD
Hydrochlorothiazide—Malaise—Temozolomide—malignant glioma	0.0035	0.00505	CcSEcCtD
Hydrochlorothiazide—Vertigo—Temozolomide—malignant glioma	0.00349	0.00503	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Temozolomide—malignant glioma	0.00347	0.00501	CcSEcCtD
Hydrochlorothiazide—Palpitations—Temozolomide—malignant glioma	0.00343	0.00495	CcSEcCtD
Hydrochlorothiazide—Myalgia—Carmustine—malignant glioma	0.00342	0.00493	CcSEcCtD
Hydrochlorothiazide—Chest pain—Carmustine—malignant glioma	0.00342	0.00493	CcSEcCtD
Hydrochlorothiazide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—HIF1A—malignant glioma	0.00341	0.0472	CbGpPWpGaD
Hydrochlorothiazide—Anxiety—Carmustine—malignant glioma	0.00341	0.00491	CcSEcCtD
Hydrochlorothiazide—Cough—Temozolomide—malignant glioma	0.00339	0.00488	CcSEcCtD
Hydrochlorothiazide—Confusional state—Carmustine—malignant glioma	0.00331	0.00477	CcSEcCtD
Hydrochlorothiazide—Myalgia—Temozolomide—malignant glioma	0.0033	0.00477	CcSEcCtD
Hydrochlorothiazide—Arthralgia—Temozolomide—malignant glioma	0.0033	0.00477	CcSEcCtD
Hydrochlorothiazide—Anxiety—Temozolomide—malignant glioma	0.00329	0.00475	CcSEcCtD
Hydrochlorothiazide—Oedema—Carmustine—malignant glioma	0.00328	0.00473	CcSEcCtD
Hydrochlorothiazide—Discomfort—Temozolomide—malignant glioma	0.00327	0.00471	CcSEcCtD
Hydrochlorothiazide—Dry mouth—Temozolomide—malignant glioma	0.00323	0.00466	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Carmustine—malignant glioma	0.00321	0.00463	CcSEcCtD
Hydrochlorothiazide—Tachycardia—Carmustine—malignant glioma	0.0032	0.00461	CcSEcCtD
Hydrochlorothiazide—Confusional state—Temozolomide—malignant glioma	0.00319	0.00461	CcSEcCtD
Hydrochlorothiazide—Oedema—Temozolomide—malignant glioma	0.00317	0.00457	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Temozolomide—malignant glioma	0.00317	0.00457	CcSEcCtD
Hydrochlorothiazide—Anorexia—Carmustine—malignant glioma	0.00313	0.00451	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Temozolomide—malignant glioma	0.0031	0.00447	CcSEcCtD
Hydrochlorothiazide—CA2—central nervous system—malignant glioma	0.00309	0.0132	CbGeAlD
Hydrochlorothiazide—Hypotension—Carmustine—malignant glioma	0.00306	0.00442	CcSEcCtD
Hydrochlorothiazide—Hyperhidrosis—Temozolomide—malignant glioma	0.00306	0.00442	CcSEcCtD
Hydrochlorothiazide—CA2—cerebellum—malignant glioma	0.00302	0.0129	CbGeAlD
Hydrochlorothiazide—Anorexia—Temozolomide—malignant glioma	0.00302	0.00435	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00299	0.00431	CcSEcCtD
Hydrochlorothiazide—Insomnia—Carmustine—malignant glioma	0.00297	0.00428	CcSEcCtD
Hydrochlorothiazide—CA4—brain—malignant glioma	0.00296	0.0126	CbGeAlD
Hydrochlorothiazide—Paraesthesia—Carmustine—malignant glioma	0.00294	0.00425	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Carmustine—malignant glioma	0.00292	0.00421	CcSEcCtD
Hydrochlorothiazide—Somnolence—Carmustine—malignant glioma	0.00291	0.0042	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00289	0.00416	CcSEcCtD
Hydrochlorothiazide—Insomnia—Temozolomide—malignant glioma	0.00287	0.00413	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Carmustine—malignant glioma	0.00285	0.00411	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Temozolomide—malignant glioma	0.00284	0.0041	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Temozolomide—malignant glioma	0.00282	0.00407	CcSEcCtD
Hydrochlorothiazide—Somnolence—Temozolomide—malignant glioma	0.00282	0.00406	CcSEcCtD
Hydrochlorothiazide—Pain—Carmustine—malignant glioma	0.0028	0.00404	CcSEcCtD
Hydrochlorothiazide—Constipation—Carmustine—malignant glioma	0.0028	0.00404	CcSEcCtD
Hydrochlorothiazide—Dyspepsia—Temozolomide—malignant glioma	0.00279	0.00402	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Temozolomide—malignant glioma	0.00275	0.00397	CcSEcCtD
Hydrochlorothiazide—Fatigue—Temozolomide—malignant glioma	0.00273	0.00394	CcSEcCtD
Hydrochlorothiazide—Constipation—Temozolomide—malignant glioma	0.00271	0.00391	CcSEcCtD
Hydrochlorothiazide—Pain—Temozolomide—malignant glioma	0.00271	0.00391	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Carmustine—malignant glioma	0.0027	0.0039	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Carmustine—malignant glioma	0.00268	0.00387	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Temozolomide—malignant glioma	0.00261	0.00376	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Carmustine—malignant glioma	0.00259	0.00374	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Carmustine—malignant glioma	0.00259	0.00374	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Temozolomide—malignant glioma	0.00259	0.00374	CcSEcCtD
Hydrochlorothiazide—Urticaria—Temozolomide—malignant glioma	0.00252	0.00363	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Temozolomide—malignant glioma	0.0025	0.00361	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Temozolomide—malignant glioma	0.0025	0.00361	CcSEcCtD
Hydrochlorothiazide—CA2—brain—malignant glioma	0.00245	0.0105	CbGeAlD
Hydrochlorothiazide—Hypersensitivity—Carmustine—malignant glioma	0.00242	0.00348	CcSEcCtD
Hydrochlorothiazide—Asthenia—Carmustine—malignant glioma	0.00235	0.00339	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Temozolomide—malignant glioma	0.00233	0.00337	CcSEcCtD
Hydrochlorothiazide—Asthenia—Temozolomide—malignant glioma	0.00227	0.00328	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Carmustine—malignant glioma	0.00224	0.00323	CcSEcCtD
Hydrochlorothiazide—Pruritus—Temozolomide—malignant glioma	0.00224	0.00323	CcSEcCtD
Hydrochlorothiazide—Dizziness—Carmustine—malignant glioma	0.00217	0.00313	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Temozolomide—malignant glioma	0.00217	0.00313	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—PIM1—malignant glioma	0.00216	0.0299	CbGpPWpGaD
Hydrochlorothiazide—Dizziness—Temozolomide—malignant glioma	0.0021	0.00302	CcSEcCtD
Hydrochlorothiazide—Vomiting—Carmustine—malignant glioma	0.00208	0.00301	CcSEcCtD
Hydrochlorothiazide—Rash—Carmustine—malignant glioma	0.00207	0.00298	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Carmustine—malignant glioma	0.00207	0.00298	CcSEcCtD
Hydrochlorothiazide—Headache—Carmustine—malignant glioma	0.00205	0.00296	CcSEcCtD
Hydrochlorothiazide—Vomiting—Temozolomide—malignant glioma	0.00201	0.0029	CcSEcCtD
Hydrochlorothiazide—Rash—Temozolomide—malignant glioma	0.002	0.00288	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Temozolomide—malignant glioma	0.002	0.00288	CcSEcCtD
Hydrochlorothiazide—Headache—Temozolomide—malignant glioma	0.00198	0.00286	CcSEcCtD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—NDRG1—malignant glioma	0.00196	0.0271	CbGpPWpGaD
Hydrochlorothiazide—Nausea—Carmustine—malignant glioma	0.00195	0.00281	CcSEcCtD
Hydrochlorothiazide—Nausea—Temozolomide—malignant glioma	0.00188	0.00271	CcSEcCtD
Hydrochlorothiazide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—malignant glioma	0.0018	0.0249	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular response to hypoxia—HIF1A—malignant glioma	0.00151	0.0209	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—NTRK3—malignant glioma	0.00144	0.0199	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—MYB—malignant glioma	0.00144	0.0199	CbGpPWpGaD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—TFRC—malignant glioma	0.00121	0.0167	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—malignant glioma	0.00119	0.0165	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00113	0.0157	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—DOCK6—malignant glioma	0.00107	0.0148	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular response to hypoxia—VEGFA—malignant glioma	0.000793	0.011	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—BMI1—malignant glioma	0.000779	0.0108	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—HES1—malignant glioma	0.000775	0.0107	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—NCOR1—malignant glioma	0.00077	0.0107	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000739	0.0102	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—PML—malignant glioma	0.000737	0.0102	CbGpPWpGaD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—TERT—malignant glioma	0.000724	0.01	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Platelet homeostasis—PTPN11—malignant glioma	0.000713	0.00988	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—RTEL1—malignant glioma	0.000704	0.00975	CbGpPWpGaD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—HIF1A—malignant glioma	0.000692	0.00959	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000676	0.00936	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—TOP2A—malignant glioma	0.000674	0.00934	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—RTEL1—malignant glioma	0.000652	0.00903	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—ATP1B2—malignant glioma	0.000647	0.00896	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000591	0.00818	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—APOD—malignant glioma	0.000575	0.00796	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000532	0.00736	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—NTRK1—malignant glioma	0.000524	0.00726	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—RTEL1—malignant glioma	0.00052	0.0072	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—HIST1H3B—malignant glioma	0.000511	0.00708	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000506	0.00701	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—RTEL1—malignant glioma	0.000498	0.0069	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Neuronal System—BCHE—malignant glioma	0.000482	0.00668	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—RTEL1—malignant glioma	0.000478	0.00662	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—ANGPT2—malignant glioma	0.000477	0.00661	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—SLC-mediated transmembrane transport—APOD—malignant glioma	0.000473	0.00655	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.000466	0.00645	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—CDKN2A—malignant glioma	0.000464	0.00643	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—NCOR1—malignant glioma	0.000458	0.00635	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—BCL2—malignant glioma	0.000457	0.00633	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Neuronal System—SLC6A3—malignant glioma	0.000453	0.00628	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—PTGS2—malignant glioma	0.000434	0.00602	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—RTEL1—malignant glioma	0.00042	0.00582	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—HIST1H3B—malignant glioma	0.000413	0.00572	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—MYB—malignant glioma	0.000409	0.00567	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—COX8A—malignant glioma	0.000404	0.0056	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—H3F3A—malignant glioma	0.000395	0.00547	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—YWHAE—malignant glioma	0.00038	0.00527	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—COX8A—malignant glioma	0.000374	0.00519	CbGpPWpGaD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000365	0.00505	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—ASMT—malignant glioma	0.000344	0.00476	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—PPARG—malignant glioma	0.000328	0.00455	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—BCAN—malignant glioma	0.000323	0.00448	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—H3F3A—malignant glioma	0.000319	0.00442	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—ASMT—malignant glioma	0.000318	0.00441	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—MYC—malignant glioma	0.000315	0.00436	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000309	0.00428	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—SOD1—malignant glioma	0.000302	0.00419	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—BCAN—malignant glioma	0.000299	0.00415	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—COX8A—malignant glioma	0.000299	0.00414	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—GSTP1—malignant glioma	0.000295	0.00408	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000294	0.00407	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—KRAS—malignant glioma	0.000291	0.00403	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—CAT—malignant glioma	0.000287	0.00397	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—COX8A—malignant glioma	0.000286	0.00397	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—CDKN2B—malignant glioma	0.000286	0.00396	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000283	0.00392	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—COX8A—malignant glioma	0.000274	0.0038	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.00027	0.00374	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—KNG1—malignant glioma	0.000263	0.00364	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—IDH2—malignant glioma	0.00026	0.00361	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—IFNA2—malignant glioma	0.000257	0.00357	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000257	0.00356	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—ASMT—malignant glioma	0.000254	0.00352	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000247	0.00342	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Neuronal System—BRAF—malignant glioma	0.000246	0.00341	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—CYP2B6—malignant glioma	0.000245	0.00339	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—SOD1—malignant glioma	0.000244	0.00338	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—ASMT—malignant glioma	0.000243	0.00337	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—COX8A—malignant glioma	0.000241	0.00334	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—IDH2—malignant glioma	0.000241	0.00334	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—APOD—malignant glioma	0.00024	0.00333	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—BCAN—malignant glioma	0.000239	0.00331	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—ASMT—malignant glioma	0.000233	0.00323	CbGpPWpGaD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000233	0.00322	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—BCAN—malignant glioma	0.000229	0.00317	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—HIF1A—malignant glioma	0.000228	0.00316	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—CYP2B6—malignant glioma	0.000227	0.00314	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—PTEN—malignant glioma	0.000225	0.00312	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—PTK2—malignant glioma	0.000224	0.00311	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—IDH1—malignant glioma	0.000224	0.0031	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000222	0.00308	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—BCAN—malignant glioma	0.000219	0.00304	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—SPHK1—malignant glioma	0.000217	0.003	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—CYP2C18—malignant glioma	0.000212	0.00294	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000212	0.00293	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—IDH1—malignant glioma	0.000207	0.00287	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Neuronal System—MDM2—malignant glioma	0.000206	0.00286	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Neuronal System—RAF1—malignant glioma	0.000205	0.00285	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—ASMT—malignant glioma	0.000205	0.00284	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—SPHK1—malignant glioma	0.000201	0.00278	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—CYP2C18—malignant glioma	0.000197	0.00272	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—BCAN—malignant glioma	0.000193	0.00267	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—IDH2—malignant glioma	0.000192	0.00267	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—PDGFB—malignant glioma	0.000188	0.00261	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—IDH2—malignant glioma	0.000184	0.00256	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—CYP2B6—malignant glioma	0.000181	0.00251	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—CAV1—malignant glioma	0.000178	0.00247	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—IDH2—malignant glioma	0.000177	0.00245	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—CYP2B6—malignant glioma	0.000173	0.0024	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—GSTT1—malignant glioma	0.000172	0.00238	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—F2—malignant glioma	0.00017	0.00235	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—FN1—malignant glioma	0.00017	0.00235	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—CYP2B6—malignant glioma	0.000166	0.0023	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—IDH1—malignant glioma	0.000165	0.00229	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—CDKN2A—malignant glioma	0.000163	0.00226	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—PIK3CG—malignant glioma	0.000163	0.00225	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PTGS1—malignant glioma	0.000161	0.00223	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—EGF—malignant glioma	0.000161	0.00223	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—SPHK1—malignant glioma	0.00016	0.00222	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—PTPN11—malignant glioma	0.00016	0.00221	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—GSTT1—malignant glioma	0.000159	0.0022	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—IDH1—malignant glioma	0.000159	0.0022	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—MDM2—malignant glioma	0.000158	0.0022	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—CYP2C18—malignant glioma	0.000157	0.00217	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—IDH2—malignant glioma	0.000155	0.00215	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—TP53—malignant glioma	0.000154	0.00213	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—SPHK1—malignant glioma	0.000153	0.00213	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—IDH1—malignant glioma	0.000152	0.00211	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—CYP2C18—malignant glioma	0.00015	0.00208	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—BCHE—malignant glioma	0.00015	0.00207	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PTGS1—malignant glioma	0.000149	0.00206	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—AKT2—malignant glioma	0.000149	0.00206	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—CXCL8—malignant glioma	0.000148	0.00205	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—SLC5A5—malignant glioma	0.000148	0.00205	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—SPHK1—malignant glioma	0.000147	0.00204	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—CYP2B6—malignant glioma	0.000146	0.00202	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—CYP2C18—malignant glioma	0.000144	0.002	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—PIK3CD—malignant glioma	0.000143	0.00198	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—BCHE—malignant glioma	0.000139	0.00192	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—SLC5A5—malignant glioma	0.000137	0.0019	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—IDH1—malignant glioma	0.000134	0.00185	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—SPHK1—malignant glioma	0.000129	0.00179	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—RAF1—malignant glioma	0.000128	0.00177	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—GSTT1—malignant glioma	0.000127	0.00176	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—CYP2C18—malignant glioma	0.000127	0.00176	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—PIK3CB—malignant glioma	0.000125	0.00173	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000123	0.0017	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GSTT1—malignant glioma	0.000122	0.00168	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—VEGFA—malignant glioma	0.00012	0.00167	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—STAT3—malignant glioma	0.000119	0.00165	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—GSTP1—malignant glioma	0.000119	0.00165	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PTGS1—malignant glioma	0.000119	0.00165	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GSTT1—malignant glioma	0.000117	0.00162	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000117	0.00161	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—CAT—malignant glioma	0.000116	0.0016	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—IL2—malignant glioma	0.000114	0.00159	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PTGS1—malignant glioma	0.000114	0.00158	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000113	0.00157	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—BCHE—malignant glioma	0.00011	0.00153	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—GSTP1—malignant glioma	0.00011	0.00153	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—NCOR1—malignant glioma	0.000109	0.00151	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PTGS1—malignant glioma	0.000109	0.00151	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—SLC5A5—malignant glioma	0.000109	0.00151	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000108	0.00149	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—CAT—malignant glioma	0.000107	0.00149	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—BCHE—malignant glioma	0.000106	0.00147	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—SLC5A5—malignant glioma	0.000105	0.00145	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GSTT1—malignant glioma	0.000102	0.00142	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—BCHE—malignant glioma	0.000102	0.00141	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—NCOR1—malignant glioma	0.000101	0.0014	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—SLC5A5—malignant glioma	0.0001	0.00139	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—VEGFA—malignant glioma	9.72e-05	0.00135	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PTGS1—malignant glioma	9.6e-05	0.00133	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—TP53—malignant glioma	9.09e-05	0.00126	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—BCHE—malignant glioma	8.93e-05	0.00124	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—CAV1—malignant glioma	8.91e-05	0.00124	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—SLC5A5—malignant glioma	8.82e-05	0.00122	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—GSTP1—malignant glioma	8.79e-05	0.00122	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—CAT—malignant glioma	8.55e-05	0.00119	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GSTP1—malignant glioma	8.43e-05	0.00117	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—KRAS—malignant glioma	8.27e-05	0.00115	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—CAV1—malignant glioma	8.26e-05	0.00114	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—CAT—malignant glioma	8.2e-05	0.00114	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PIK3CG—malignant glioma	8.12e-05	0.00112	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GSTP1—malignant glioma	8.08e-05	0.00112	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—NCOR1—malignant glioma	8.08e-05	0.00112	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—CAT—malignant glioma	7.86e-05	0.00109	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PPARG—malignant glioma	7.84e-05	0.00109	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—NCOR1—malignant glioma	7.75e-05	0.00107	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—PIK3CA—malignant glioma	7.59e-05	0.00105	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PIK3CG—malignant glioma	7.52e-05	0.00104	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—NCOR1—malignant glioma	7.43e-05	0.00103	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—TP53—malignant glioma	7.35e-05	0.00102	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PPARG—malignant glioma	7.26e-05	0.00101	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PIK3CD—malignant glioma	7.14e-05	0.000989	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GSTP1—malignant glioma	7.1e-05	0.000984	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—CAT—malignant glioma	6.91e-05	0.000958	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PIK3CD—malignant glioma	6.61e-05	0.000916	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—CAV1—malignant glioma	6.59e-05	0.000912	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—NCOR1—malignant glioma	6.53e-05	0.000904	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—CAV1—malignant glioma	6.31e-05	0.000875	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PIK3CB—malignant glioma	6.22e-05	0.000862	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—AKT1—malignant glioma	6.2e-05	0.000859	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PTGS2—malignant glioma	6.16e-05	0.000854	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—CAV1—malignant glioma	6.05e-05	0.000839	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PIK3CG—malignant glioma	6e-05	0.000831	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PPARG—malignant glioma	5.79e-05	0.000802	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PIK3CB—malignant glioma	5.76e-05	0.000799	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PIK3CG—malignant glioma	5.75e-05	0.000797	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PTGS2—malignant glioma	5.71e-05	0.000791	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PPARG—malignant glioma	5.55e-05	0.000769	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PIK3CG—malignant glioma	5.51e-05	0.000764	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PTEN—malignant glioma	5.38e-05	0.000745	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PPARG—malignant glioma	5.32e-05	0.000737	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—CAV1—malignant glioma	5.32e-05	0.000737	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PIK3CD—malignant glioma	5.27e-05	0.000731	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PIK3CD—malignant glioma	5.06e-05	0.0007	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PTEN—malignant glioma	4.98e-05	0.00069	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	4.87e-05	0.000675	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PIK3CG—malignant glioma	4.85e-05	0.000672	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PIK3CD—malignant glioma	4.85e-05	0.000672	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PPARG—malignant glioma	4.68e-05	0.000648	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PIK3CB—malignant glioma	4.6e-05	0.000637	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PTGS2—malignant glioma	4.55e-05	0.000631	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PIK3CB—malignant glioma	4.41e-05	0.000611	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PTGS2—malignant glioma	4.37e-05	0.000605	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PIK3CD—malignant glioma	4.26e-05	0.00059	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PIK3CB—malignant glioma	4.23e-05	0.000585	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PTGS2—malignant glioma	4.19e-05	0.00058	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PTEN—malignant glioma	3.97e-05	0.00055	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PTEN—malignant glioma	3.81e-05	0.000528	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PIK3CA—malignant glioma	3.79e-05	0.000525	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PIK3CB—malignant glioma	3.71e-05	0.000515	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PTGS2—malignant glioma	3.68e-05	0.00051	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PTEN—malignant glioma	3.65e-05	0.000506	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PIK3CA—malignant glioma	3.51e-05	0.000487	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PTEN—malignant glioma	3.21e-05	0.000445	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—AKT1—malignant glioma	3.1e-05	0.000429	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—AKT1—malignant glioma	2.87e-05	0.000398	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PIK3CA—malignant glioma	2.8e-05	0.000388	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PIK3CA—malignant glioma	2.69e-05	0.000372	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PIK3CA—malignant glioma	2.58e-05	0.000357	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—AKT1—malignant glioma	2.29e-05	0.000317	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PIK3CA—malignant glioma	2.26e-05	0.000314	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—AKT1—malignant glioma	2.19e-05	0.000304	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—AKT1—malignant glioma	2.1e-05	0.000291	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—AKT1—malignant glioma	1.85e-05	0.000256	CbGpPWpGaD
